Related Experiment Video
Updated: Aug 20, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by
Amarsanaa Jazag1, Hideaki Ijichi, Fumihiko Kanai
1Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Abstract:
The transforming growth factor-beta (TGF-beta)-Smad signaling pathway inhibits the growth of human epithelial cells and plays a role in tumor suppression. The Smad4 gene is mutated or deleted in 50% of pancreatic cancers. In this study, we succeeded in establishing Smad4 knockdown (S4KD) pancreatic cancer cell lines using the stable RNA interference (RNAi) method. Smad4 protein expression was reduced dramatically and TGF-beta-Smad signaling was markedly inhibited in the S4KD cell lines. The S4KD and control cells were stimulated with TGF-beta and analysed using a cDNA microarray that contained 3756 genes, in order to screen for target molecules downstream of TGF-beta. The microarray analysis revealed that 187 S4KD genes and 155 genes in the control cells were regulated immediately upon TGF-beta stimulation. Quantitative RT-PCR analysis on several of these genes produced results that corroborated the outcome of the microarray analysis. Most of the genes in the S4KD and control cells identified by the array differed, which suggests signaling pathways that differ according to Smad4 status. Of the identified genes, 246 have not been reported previously as genes that lie downstream of TGF-beta. Genes that are involved in cell proliferation, adhesion, and motility were found to be regulated differentially with respect to S4KD and control cells. Cell migration induced by TGF-beta was inhibited in the S4KD cells, which might be associated with a different regulation of integrin beta7. The knock down of a specific gene using stable RNAi appears to be a promising tool for analysing endogenous gene function.
Insights
Smad4 gene knockdown in pancreatic cancer cells inhibits transforming growth factor-beta (TGF-beta) signaling. This study identified novel TGF-beta target genes and revealed Smad4
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- The transforming growth factor-beta (TGF-beta)-Smad signaling pathway is crucial for epithelial cell growth inhibition and tumor suppression.
- Smad4 gene mutations or deletions are prevalent in approximately 50% of human pancreatic cancers, highlighting its significance in tumorigenesis.
Purpose of the Study:
- To establish Smad4 knockdown (S4KD) pancreatic cancer cell lines using stable RNA interference (RNAi) to investigate TGF-beta-Smad signaling.
- To identify novel downstream target genes of TGF-beta signaling regulated by Smad4 status using cDNA microarray analysis.
Main Methods:
- Generation of S4KD pancreatic cancer cell lines via stable RNA interference (RNAi) to reduce Smad4 protein expression.
- Stimulation of S4KD and control cells with TGF-beta, followed by cDNA microarray analysis of 3756 genes.
- Validation of microarray results using quantitative RT-PCR (qRT-PCR).
Main Results:
- TGF-beta-Smad signaling was markedly inhibited in S4KD cell lines.
- Microarray analysis identified 187 S4KD-specific and 155 control-specific genes regulated by TGF-beta stimulation.
- Differential regulation of genes involved in cell proliferation, adhesion, and motility was observed between S4KD and control cells.
- TGF-beta-induced cell migration was inhibited in S4KD cells, potentially linked to altered integrin beta7 regulation.
- 246 novel TGF-beta downstream genes were identified.
Conclusions:
- Stable RNAi is an effective tool for analyzing endogenous gene function.
- Smad4 status significantly influences TGF-beta signaling pathways, impacting cell proliferation, adhesion, and motility.
- The findings provide insights into the role of Smad4 in pancreatic cancer and identify potential therapeutic targets.
More Related Videos
Related Concept Videos
Experimental RNAi
TGF - β Signaling Pathway
MicroRNAs
MicroRNAs

